Market Place
Sourcing Support
Assertio Shares Rolvedon® Same-Day Dosing Study Results
13 Dec 2024 //
GLOBENEWSWIRE
Assertio Appoints Paul Schwichtenberg As CTO, Mary Pietryga As CCO
12 Dec 2024 //
GLOBENEWSWIRE
Buxton Calls for Senate Hearing on Assertio Clinical Data Fraud
15 Nov 2024 //
BUSINESSWIRE
Assertio says activist investor`s claims are `without merit`
12 Nov 2024 //
FIERCE PHARMA
Buxton Releases Evidence of Product-Related Fraud at Assertio
11 Nov 2024 //
BUSINESSWIRE
Assertio Response to Letter from Short-seller
11 Nov 2024 //
GLOBENEWSWIRE
Assertio Reports Q3 2024 Financial Results
11 Nov 2024 //
GLOBENEWSWIRE
Assertio Holdings to Report Q3 2024 Financial Results on Nov 11
30 Oct 2024 //
GLOBENEWSWIRE
Assertio To Participate In Maxim Healthcare Summit on Oct 15, 2024
11 Oct 2024 //
GLOBENEWSWIRE
Assertio Reports Inducement Grants Under NASDAQ LR 5635(c)(4)
04 Oct 2024 //
GLOBENEWSWIRE
Assertio to Participate in HC Wainwright and Lake Street Conferences
03 Sep 2024 //
GLOBENEWSWIRE
Assertio Reports Second Quarter 2024 Financial Results
07 Aug 2024 //
GLOBENEWSWIRE
Assertio Holdings To Report Q2 2024 Results On August 7
24 Jul 2024 //
GLOBENEWSWIRE
Assertio Holdings Reports Inducement Grants Under NASDAQ Rule
09 Jul 2024 //
GLOBENEWSWIRE
Assertio Reports Inducement Grants Under Nasdaq Rule 5635(c)(4)
06 Jun 2024 //
GLOBENEWSWIRE
Assertio to Participate in the Sidoti Small Cap Conference on June 12, 2024
05 Jun 2024 //
GLOBENEWSWIRE
Assertio Announces the Appointment of Brendan P. O™Grady as New CEO
29 May 2024 //
GLOBENEWSWIRE
Assertio At JMP Life Sciences Conference In New York
10 May 2024 //
GLOBENEWSWIRE
Assertio Reports First Quarter 2024 Financial Results
06 May 2024 //
GLOBENEWSWIRE
Sig Kirk Joins Assertio Board of Directors
03 Apr 2024 //
GLOBENEWSWIRE
Assertio to Present at LD Micro Invitational Conference in New York City
01 Apr 2024 //
GLOBENEWSWIRE
Assertio Reports Fourth Quarter and Full Year 2023 Financial Results
11 Mar 2024 //
GLOBENEWSWIRE
Enforcement Report - Week of November 15, 2023
15 Nov 2023 //
FDA
Assertio Appoints Dr. Howard Franklin as Senior Vice President, Medical
06 Mar 2023 //
GLOBENEWSWIRE
Assertio Announces Exchange Offer of $30M of Currently Outstanding 6.50% Convertible Senior Notes
23 Feb 2023 //
GLOBENEWSWIRE
Assertio Announces Partnership with the Lennox-Gastaut Syndrome (LGS) Foundation
17 Jan 2023 //
GLOBENEWSWIRE
Aquestive offloads film formulation seizure drug to Assertio
31 Oct 2022 //
FIERCEPHARMA
Assertio Announces Closing of $70 Million Convertible Senior Notes Offering
25 Aug 2022 //
GLOBENEWSWIRE
Assertio Prices $60 Million Convertible Senior Notes Offering to Refinance
22 Aug 2022 //
GLOBENEWSWIRE
Assertio Reports Second Quarter 2022 Financial Results
08 Aug 2022 //
GLOBENEWSWIRE
Assertio Reports First Quarter 2022 Financial Results
09 May 2022 //
GLOBENEWSWIRE
Assertio Holdingsto Report First Quarter 2022 Financial Results After
22 Apr 2022 //
GLOBENEWSWIRE
Assertio Reports Q4 and FY 2021 Financial Results
09 Mar 2022 //
GLOBENEWSWIRE
Assertio to Participate in the H.C. Wainwright BioConnect Virtual Conference
10 Jan 2022 //
GLOBENEWSWIRE
This arthritis drug cost $198 in 2008. Now it`s more than $10,000
19 Oct 2021 //
AXIOS
Assertio Reports Second Quarter 2021 Financial Results
05 Aug 2021 //
GLOBENEWSWIRE
Assertio Completed Merger with Zyla Life Sciences
20 May 2020 //
PRNEWSWIRE
Assertio`s Agrees to Merge with Zyla Life to Create Synergistic Portfolio
16 Mar 2020 //
IN-PHARMATECHNOLOGIST
Collegium to acquire U.S. rights to Nucynta from Assertio for $375M
27 Feb 2020 //
BIOWORLD
Assertio`s Announces Sale of NUCYNTA® Franchise to Collegium for $375.0 Million
07 Feb 2020 //
YAHOO
Assertio Therapeutics Announces Sale of NUCYNTA® Franchise to Collegium Pharma
06 Feb 2020 //
GLOBENEWSWIRE
Assertio Therapeutics Announces Sale of Gralise® for Total Transaction Value of $127.5 million "
12 Dec 2019 //
GLOBENEWSWIRE
FDA rebuffs little Assertio Therapeutics` long-acting ACTH formulation
23 Oct 2019 //
ENDPTS
Assertio Therapeutics Provides Regulatory Update on Long-Acting Cosyntropin
22 Oct 2019 //
YAHOO
Assertio down 47% on shareholder dilution in convertible debt exchange deal
09 Aug 2019 //
SEEKINGALPHA
Egalet Reports First Quarter 2019 Financial Results and Plan to Change Company
10 Jul 2019 //
ZYLA LIFE SCIENCES
Adare acquires Egalet’s proprietary “Parvulet®” technology platform
15 Apr 2019 //
PRESS RELEASE
Egalet buys pain med from Iroko, then jacks the price up 70%
16 Feb 2019 //
FIERCE PHARMA
Egalet Announces National Pharmacy Benefit Manager to Cover SPRIX®
07 May 2018 //
PR NEWSWIRE
Egalet Announces Two Large Northeast Regional Health Plans Placed ARYMO® ER
17 Apr 2018 //
PR NEWSWIRE
Egalet`s Partner OraPharma Begins Promotion of SPRIX® Nasal Spray
23 Jan 2018 //
PR NEWSWIRE
